Abstract
Objectives: WHO grade I meningiomas may show growth after radiosurgical treatment, which can result in the need for additional treatments, for example surgery. It is therefore essential to be able to predict this aggressive behavior, which so far cannot be established with clinical parameters. There is increasing evidence that certain biomarkers are associated with recurrence and regrowth of meningiomas. The aim of this study was to identify biomarkers to predict regrowth of WHO grade I meningiomas after radiosurgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurological Surgery Part B: Skull Base
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
